Healios KK News

Healios KK: Extraordinary Report

May 13 02:22

Healios KK: Confirmation letter

May 13 02:21

Healios KK: Quarterly Report - 14th quarter 1st quarter (2024/01/01 - 2024/03/31)

May 13 02:20

Healios KK: Financial results for the 1st quarter of 2024

May 13 02:20

Healios KK: Presentation of financial results for the 1st quarter of the fiscal year ending 2024/12

May 13 02:20

Healios KK: Notice regarding the recording of financial income and financial expenses

May 13 02:20

Healios KK: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)

May 13 02:20

Healios KK: Corporate Governance Report 2024/04/12

Apr 11 22:47

Healios KK: Joint Research Agreement with AND medical to Utilize Healios Technology and Culture Supernatant

Apr 8 21:30

Healios KK: Announcement of the conclusion of a joint research agreement with AND Medical to utilize culture supernatants

Apr 8 21:30

Healios KK: Healios Acquires Substantially All of the Assets of Athersys, Inc. Free and Clear of Liabilities, Becomes Sole Owner of MultiStem

Apr 3 19:00

Healios KK: Acquisition of all substantial assets of Assassis' - acquisition of sole rights to the somatic stem cell regenerative medicine product MultiStem Cell

Apr 3 19:00

Healios KK: Confirmation letter

Mar 28 01:20

Helios: Financial Report - Term 13 (2023/01/01 - 2023/12/31)

Mar 28 01:19

Helios: Internal Control Report - Term 13 (2023/01/01 - 2023/12/31)

Mar 28 01:19

Helios: Extraordinary Report

Mar 28 01:14

Healios KK: Corporate Governance Report 2024/03/28

Mar 27 20:57

Healios KK: Announcement of the presentation of research results on enK cell hepatocellular carcinoma at the 23rd Annual Meeting of the Japanese Society for Regenerative Medicine

Mar 19 01:00

Healios KK: Matters relating to business plans and growth potential

Mar 19 01:00

Healios KK: Presentation of the research results of Healios’ eNK cells on mesothelioma at AACR Annual Meeting 2024

Mar 13 03:00